Green Light Effects on Anxiety
NCT04871087 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2022-03-15
Summary
The main goal of this study is to determine whether exposure to a narrow band of green light (NBGL) improves outcome of psychotherapy sessions for the treatment of anxiety.
This is a within-subject study design that examines NBGL effects (as compared to white light) on anxiety level and treatment success, as evaluated by the treating psychotherapist and the patient. For each participant, the study will consist of 8 therapy sessions, each lasting 60 minutes, in which light conditions will be presented in the following order
Session 1: White light, Session 2: white light, Session 3: NBGL (i.e., green light), Session 4: NBGL, Session 5: NBGL, Session 6: NBGL, Session 7: White light, Session 8: White light
Effects of lights (white vs.NBGL) on anxiety level will be evaluated at the beginning and end of each therapy session by the patient, using a validated questionnaire. At the end of each session, the treating psychotherapist will fill another evaluation form that summarizes her/his impression of the treatment success or lack of.
Conditions
Interventions
- DEVICE
-
Green Light
The Allay Lamp is a consumer product currently available and widely used in the US. It emits low intensity (1-10lux)narrow band (20nm) green light (peak wavelength 520nm) that is marketed as non-irritating to users. In that context, it is not a medical device and does not require a 510(k). However, we believe that light likely also has benefits for sleep. To better understand its effects,we are planning to conduct the proposed study. In that context, the Allay Lamp would be considered an investigational medical device because it has not been cleared or approved by FDA for the intended purpose of treating sleep. No FDA submission should be necessary for this study using 21 C.F.R. 812.3, because the Allay Lamp is a non-significant risk (NSR) device: It is not an implant It is not intended for use in supporting or sustaining human life The Allay Lamp provides a very low risk light-based therapy. The light provides no more risk than any other table lamp available on the market today.
Sponsors & Collaborators
-
The Green Light Study Center
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 95 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-01
- Primary Completion
- 2022-04-01
- Completion
- 2022-04-01
Countries
- United States
Study Locations
More Related Trials
-
Developing a Novel Digital Therapeutic for the Treatment of Generalized Anxiety Disorder
NCT03683472 ·Status: COMPLETED ·Phase: NA
-
Reducing Anxiety and Stress in Primary Care Patients
NCT03794089 ·Status: COMPLETED ·Phase: NA
-
Brief Anxiety Sensitivity Treatment for Obsessive Compulsive Symptoms
NCT02635178 ·Status: COMPLETED ·Phase: NA
-
Hybrid Trial of Brief Cognitive-Behavioral Therapy for Health Anxiety in Primary Care
NCT03789084 ·Status: COMPLETED ·Phase: NA
-
Intervention for Anxiety After Falls
NCT01268657 ·Status: COMPLETED ·Phase: PHASE1
-
Investigating How the Brain Processes Different Experiences
NCT06051084 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Psychobiological Responses Following Exercise and Brain Stimulation
NCT06874595 ·Status: RECRUITING ·Phase: NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
NCT04895995 ·Status: RECRUITING ·Phase: NA
-
Does Increasing Attentional Control Decrease Acute Fear Response
NCT04080115 ·Status: COMPLETED ·Phase: NA
-
Investigating Attention Patterns in Young People With Anxiety
NCT03546946 ·Status: UNKNOWN ·Phase: NA
-
Identifying Decision Making Parameters in Healthy Volunteers and Anxiety Patients
NCT05092971 ·Status: COMPLETED ·Phase: NA
-
Anxiety in Older Veterans
NCT02400723 ·Status: COMPLETED ·Phase: NA
-
Attention Bias Modification Training in Youth With Subthreshold Impairing Anxiety
NCT02410967 ·Status: COMPLETED ·Phase: NA
-
Pharmacological Treatment of Generalized Anxiety Disorder in the Elderly
NCT00701675 ·Status: COMPLETED ·Phase: PHASE4
-
Tutorial of Clinical Trial Registration
NCT03481452 ·Status: UNKNOWN ·Phase: NA
-
Electrical Vestibular Stimulation (VeNS), Compared to a Sham Control For The Management Of Anxiety
NCT05907967 ·Status: COMPLETED ·Phase: NA
-
Short Term Group Therapy for Anxiety Disorder
NCT00229281 ·Status: COMPLETED ·Phase: NA
-
Acceptance-Based Treatment for Generalized Anxiety Disorder
NCT00073632 ·Status: COMPLETED ·Phase: PHASE1
-
Augmentation of Exposure Using Positive Mental Rehearsal in Individuals With Increased Social Anxiety
NCT06564402 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions
NCT04478526 ·Status: COMPLETED ·Phase: NA
-
Optimizing Psychotherapy for Anxiety Disorders
NCT03945617 ·Status: UNKNOWN ·Phase: NA
-
Tailored Internet-administrated Treatment of Panic Symptoms - A Randomised Controlled Trial
NCT01296321 ·Status: UNKNOWN ·Phase: NA
-
Exposure Therapy for Late-life Anxiety
NCT06770517 ·Status: RECRUITING ·Phase: NA
-
Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and OCD
NCT02713516 ·Status: COMPLETED ·Phase: NA
-
Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)
NCT00219349 ·Status: COMPLETED ·Phase: PHASE4